Smart Healthcare Products Market: Increasing Healthcare Spending to Boost Market Growth

  • According to Transparency Market Research’s latest report on the global smart healthcare products market for the historical period 2017–2018 and forecast period 2019–2027, growing digitalization in healthcare industry, growth in number of SMEs and large enterprises dealing in smart healthcare products, and increasing government initiative to promote smart healthcare are projected to drive the global smart healthcare products market during the forecast period
  • According to the report, the global smart healthcare products market was valued at US$ 37.5 Bn in 2018 and is anticipated to expand at a CAGR of 8.8% from 2019 to 2027

Read Report Overview -

Greater Role of Government in Developing Smart Healthcare Ecosystem: Key Drivers

  • Governments' significant and developing part as payer, controller, and market-shaper in the worldwide smart healthcare division cannot be downplayed.
  • In many nations, governing authorities are major the funder and supplier of medicinal services for its population; this is an exceptionally costly obligation, as population is increasing
  • Globally, various governments are implementing expansive changes by cutting expenses and enhancing the nature of their medical services frameworks.
  • India's newly formed government is implementing a healthcare strategy to concentrate on minimizing the lack of healthy sustenance, enhancing the utilization of crucial medications, expanding inoculation, and modernizing open doctors' facilities. The administration needs an all-encompassing medical services framework that is universally accessible.

Request Brochure of Report -

Increasing Healthcare Spending Boost Market Growth

  • No industry appears to be more out-of-venture with the predominant macroeconomic account than the healthcare sector. As opposed to trepidation, common stagnation, slow development, healthcare experts will probably stress about extreme spending growth, rising costs, and in-satisfactory limit. In fact, the same factors narrowing development rates-societal maturing in developed economies and development in emerging market (EM) economies-are boosting medical services spending and the industry’s share of global GDP.
  • The healthcare sector is not immune to continual ups and downs, yet rising expectations from emerging countries for the availability of everyday comforts and overall aging in developed economies are liable to guarantee that the healthcare business develops much faster than the worldwide economy.
  • Faster development makes the healthcare sector a one-of-a-kind destination for capital generation in the current financial environment. It is believed that financial specialists ought to deploy capital deliberately in light of particular opportunities created by rapidly emerging markets healthcare foundation growth and a new era of development and cost cognizance in developed economies.

Request for Analysis of COVID-19 Impact on Smart Healthcare Products Market-

Cost and Privacy Issues to Hamper Market

  • The steep cost of smart medical items and supplier vulnerability with respect to the rate of return impacts smart healthcare item appropriation
  • In a project started by the Office of the National Coordinator for Health Information (ONC) (U.S.), researchers found that healthcare facility administrators and physicians who had embraced smart medical care noticed that any additions in proficiency were counterbalanced by decreased efficiency as the innovation was executed, and the need to expand skilled staff to keep up the framework.
  • The U.S. Congressional Budget Office presumed that cost savings might happen in large integrated establishments, and not in small healthcare facilities. Office-based doctors specifically might see no advantage in buying such items and might even endure monetary damage.
  • In Germany, the U.K., and the U.S., the idea of a national concentrated server model of healthcare information has been inadequately received. Issues of protection and security in such a model have been a major concern.
  • Recent disclosures of "secure" information breaches at centralized information storehouses, in banking and other monetary establishments, in the retail business, and from government databases, have created worry about putting away electronic medical records in a central location. Records that are exchanged over the Internet are liable to the same security issues as other kinds of information exchanged over the Internet.

Request for Custom Research -

Global Smart Healthcare Products Market: Competitive Landscape

  • This report profiles major players in the global smart healthcare products market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global smart healthcare products market is highly fragmented, with the presence of a number of international as well as regional players

Pre Book Smart Healthcare Products Market Report -

Global Smart Healthcare Products Market: Key Developments

Key players in the global smart healthcare products market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global smart healthcare products market. A few expansion strategies adopted by players operating in the global smart healthcare products market are:

  • In February 2020, Velóce Corporation, a Denver startup announced that the company is developing the SmartTab drug delivery and monitoring system, a remote-controlled ingestible capsule that contains an electronic receiver, monitor, actuator and active ingredients.
  • In May 2019, Elucid mHealth launched smart pill bottle to monitor patient adherence
  • In April 2019, Alien Technology launched its next-generation of Higgs RFID semiconductor integrated circuits, Higgs-9 IC. The product enables enterprise critical applications to run smarter, faster and with quicker ROI in RFID deployments.
  • In November 2017, Food and Drug Administration Approved Abilify MyCite of Otsuka America Pharmaceutical, Inc. It is the first digital pill that has been approved by FDA.
  • The report on the global smart healthcare products market discussed individual strategies, followed by company profiles of manufacturers of smart healthcare products. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global smart healthcare products market.

Browse More Trending Reports by Transparency Market Research:        

Pseudobulbar Treatment Market:              

Mycoplasma Plate Antigens Market:

Allergy Rapid Test Market:

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.


Mr. Rohit Bhisey
Transparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453



Back to news